Get the tools used by (smart)2 investors.

Avg Price / LTM FCF (5y) for Inozyme Pharma Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

INZY: Inozyme Pharma Inc

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The compan...

1.00 USD
Price
USD
Fair Value
Upside
0.98 - 7.79
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Inozyme Pharma Inc's Avg Price / LTM FCF (5y):

INZYHLTH.USAIMDCDNAWINTOLMAVCNX-100.0x-60.0x-20.0x

Performance Summary
  • Inozyme Pharma Inc's avg price / ltm fcf (5y) is -5.6x

How does Inozyme's Avg Price / LTM FCF (5y) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Inozyme Pharma Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Avg Price / LTM FCF (5y)

Hide this widget
price_to_fcf_ltm_avg_5y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Avg Price / LTM FCF (5y) in the valuation category include:

  • Price, Low Today - The day's lowest trading price of an instrument or asset so far today
  • Market Cap / Fwd AFFO - Indicates the multiple of projected adjusted funds from operations (AFFO) that stock investors are willing to pay for one share of the firm.
  • YTD Price Total Return - The total change in price, adjusted for splits, so far this calendar year.
  • Avg EV / EBITDA (5y) - Five-year quarterly average EV / EBITDA.
View Full List

Search for metric or datapoint

Avg Price / LTM FCF (5y)

Five-year quarterly average P/FCF ratio.

Definition of Avg Price / LTM FCF (5y)

Hide this widget
Five-year quarterly average P/FCF ratio.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-213.2x-118.2x-23.2x154.4x0200400600

The chart above depicts the distribution of avg price / ltm fcf (5y) for companies operating in the Healthcare sector in the Developed economic region. Over 2,460 companies were considered in this analysis, and 2,369 had meaningful values. The average avg price / ltm fcf (5y) of companies in the sector is -3.3x with a standard deviation of 33.8x.

Inozyme Pharma Inc's Avg Price / LTM FCF (5y) of -5.6x ranks in the 43.5% percentile for the sector. The following table provides additional summary stats:

Avg Price / LTM FCF (5y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,467
Included Constituents2,369
Min-216.4x
Max149.0x
Median-4.3x
Mean-3.3x
Standard Deviation33.8x

You can find companies with similar avg price / ltm fcf (5y) using this stock screener.

All rights reserved. Terms Of Use